Active: new fund May 2026 Verified 7 Nov 2026
Lauxera Capital Partners
Paris and San Francisco based growth equity fund that invests EUR 20 to 100 million in healthtech companies at the early profitability stage, across medical devices, digital health, diagnostics and life science tools.
- Type
- VC firm
- Location
- Paris, France
- Stages
- Growth
- Sectors
- Healthtech and life sciences, Medtech, Diagnostics, Healthtech
- Fund size / AUM
- Over EUR 800 million under management across Lauxera Growth I and II (own site)
- Website
- lauxera.com
Contacts on file
For Lauxera Capital Partners, the paid file holds: 4 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
OrganOxNatural CyclesGenePlanetBioLaminaAcandis
Sources
- lauxera.com/
- lauxera.com/portfolio/
- lauxera.com/team/
- lauxera.com/contact/
- www.franceinvest.eu/annuaire-des-membres/?annuaire_crm_actif_associe=actif
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 14 lists
Medtech investors in Europe (45)Healthtech investors in Paris (60)Venture capital firms in France (81)Growth-stage medtech investors (107)Startup investors in Paris (114)Startup investors in France (189)Growth-stage investors in Europe (276)Healthtech investors in Europe (291)Growth-stage healthtech investors (316)Venture capital firms in Europe (412)Medtech investors (457)Growth-stage investors (705)Startup investors in Europe (725)Healthtech investors (1,207)